Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS

Harris, S; Tran, JQ; Southworth, H; Spencer, CM; Cree, BAC; Zamvil, SS

Harris, S (corresponding author), Bristol Myers Squibb Co, Princeton, NJ 08543 USA.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020; 7 (5):

Abstract

Objective To better understand ozanimod's mechanism of action (MOA), we conducted exploratory analyses from a phase 1 study to characterize ozanimod's......

Full Text Link